Cellectis (CLLS) Asset Utilization Ratio (2015 - 2026)
Cellectis' (CLLS) quarterly Asset Utilization Ratio came in at 0.23 in Q1 2026, up 79.97% year-on-year from 0.13 in Q1 2025, and up 1.72% quarter-over-quarter from 0.23 in Q4 2025.
Cellectis (CLLS) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
Cellectis' Asset Utilization Ratio history runs 12 years deep, the most recent figure standing at 0.23 for Q1 2026.
- On a quarterly basis, Asset Utilization Ratio rose 79.97% year-over-year to 0.23 in Q1 2026; TTM through Mar 2026 was 0.23, a 79.97% increase from a year earlier, with the FY2025 full-year figure at 0.21, up 78.13% from the prior year.
- Asset Utilization Ratio grew to 0.23 in Q1 2026 per CLLS's latest filing, from 0.23 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.23 in Q1 2026 and bottomed at 0.0 in Q4 2023.
- The 5-year median for Asset Utilization Ratio is 0.07 (2024), against an average of 0.1.
- Across the five-year window, Asset Utilization Ratio sank 96.08% in 2023 and jumped 3736.69% in 2024, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.07 in 2022, then sank by 96.08% to 0.0 in 2023, then soared by 3736.69% to 0.11 in 2024, then surged by 111.67% to 0.23 in 2025, then rose by 1.72% to 0.23 in 2026.
- Per Business Quant, the three latest CLLS Asset Utilization Ratio figures stand at 0.23 (Q1 2026), 0.23 (Q4 2025), and 0.22 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | 0.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.23 |
| Dec 31, 2025 | 0.23 |
| Sep 30, 2025 | 0.22 |
| Jun 30, 2025 | 0.16 |
| Mar 31, 2025 | 0.13 |
| Dec 31, 2024 | 0.11 |
| Sep 30, 2024 | 0.07 |
| Jun 30, 2024 | 0.03 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.08 |
| Jun 30, 2023 | 0.07 |
| Mar 31, 2023 | 0.07 |
| Dec 31, 2022 | 0.07 |
| Sep 30, 2022 | 0.04 |
| Jun 30, 2022 | 0.06 |
| Mar 31, 2022 | 0.09 |
| Dec 31, 2021 | 0.14 |
| Sep 30, 2021 | 0.13 |
| Jun 30, 2021 | 0.13 |